Jennifer Good

Jennifer Good is Trevi’s co-founder and has served as a member of the board of directors and as the President and CEO since Trevi’s inception in 2011. Previously, Ms. Good served at Penwest Pharmaceuticals, where she held various positions including President and CEO, COO, and CFO. Ms. Good currently serves on the board of Rhythm Pharmaceuticals, Inc., a publicly traded company, the Friedreich’s Ataxia Research Alliance (FARA), a patient advocacy group, and is Treasurer for a non-profit organization, Newtown Youth and Family Services. Ms. Good is also one of the board members of the BIO Emerging Companies Section (ECS) Governing Board, a board member of the Executive Women in Bio, CT Chapter and is a Co-Chair of the New Haven Regional Bioscience Collaborative. Ms. Good received a Bachelor of Business Administration degree with a concentration in accounting from Pacific Lutheran University in 1987.